** CStone Pharmaceuticals 2616.HK slides 13% to HK$3, lowest since February 25
** Stock set for biggest one-day pct decline since March 7, 2024; top pct loser on Hong Kong bourse
** Chinese biopharma developer plans to sell 80 mln new shares to third party investors to raise HK$234.6 mln ($30.2 mln) for R&D and general corporate purposes
** Says shares will be issued at HK$2.933, representing ~15% discount to Tuesday's close of HK$3.45
** Stock gains 30.4% YTD
($1 = HK$7.7808)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.